MAKO Surgical Stock Price, News & Analysis (NASDAQ:MAKO)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About MAKO Surgical (NASDAQ:MAKO)

MAKO Surgical logoMAKO Surgical Corp. (MAKO) is a medical device company, which markets its advanced robotic arm solution, joint specific applications for the knee and hip and orthopedic implants for orthopedic procedures. The Company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific, osteoarthritic disease. MAKOplasty is performed using the Company's RIO Robotic Arm Interactive Orthopedic system (RIO). The RIO is a technology platform that utilizes tactile guided robotic arm technology and patient specific planning and visualization to offer reproducible precision to surgeons. In October 2013, MAKO Surgical Corp. completed the acquisition of Pipeline Biomedical Holdings, Inc.'s business, which is engaged in the design, development, manufacture and commercialization of orthopedic devices and related instruments for use with both robotic devices and manual medical procedures.

Receive MAKO News and Ratings via Email

Sign-up to receive the latest news and ratings for MAKO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Health Care Equipment & Supplies
Sub-IndustryHealth Care Equipment


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

MAKO Surgical (NASDAQ:MAKO) Frequently Asked Questions

What is MAKO Surgical's stock symbol?

MAKO Surgical trades on the NASDAQ under the ticker symbol "MAKO."

Who are some of MAKO Surgical's key competitors?

How do I buy MAKO Surgical stock?

Shares of MAKO Surgical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact MAKO Surgical?

MAKO Surgical's mailing address is 2555 Davie Rd, DAVIE, FL 33317-7424, United States. The medical device company can be reached via phone at +1-954-9272044.

MarketBeat Community Rating for MAKO Surgical (MAKO)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  105 (Vote Outperform)
Underperform Votes:  176 (Vote Underperform)
Total Votes:  281
MarketBeat's community ratings are surveys of what our community members think about MAKO Surgical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MAKO Surgical (NASDAQ:MAKO) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


MAKO Surgical (NASDAQ:MAKO) Earnings History and Estimates Chart

Earnings by Quarter for MAKO Surgical (NASDAQ:MAKO)

MAKO Surgical (NASDAQ MAKO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/5/2013Q3 2013($0.12)($0.31)$33.05 million$22.76 millionViewN/AView Earnings Details
7/30/2013Q2 2013($0.22)($0.42)$28.53 million$28.20 millionViewN/AView Earnings Details
5/7/2013Q1 2013($0.19)($0.21)$24.82 million$24.81 millionViewN/AView Earnings Details
2/26/2013Q4 2012($0.13)($0.13)$30.80 million$30.28 millionViewN/AView Earnings Details
11/7/2012Q312($0.16)($0.15)$27.48 million$29.17 millionViewN/AView Earnings Details
8/1/2012($0.22)($0.20)ViewN/AView Earnings Details
5/7/2012($0.20)($0.28)ViewN/AView Earnings Details
3/6/2012($0.14)($0.14)ViewN/AView Earnings Details
11/9/2011($0.23)($0.24)ViewN/AView Earnings Details
8/8/2011($0.24)($0.24)ViewN/AView Earnings Details
5/3/2011($0.24)($0.27)ViewN/AView Earnings Details
3/1/2011Q4 2010($0.20)($0.26)ViewN/AView Earnings Details
11/2/2010Q3 2010($0.23)($0.27)ViewN/AView Earnings Details
8/3/2010Q2 2010($0.26)($0.26)ViewN/AView Earnings Details
5/6/2010Q1 2010($0.26)($0.29)ViewN/AView Earnings Details
3/8/2010Q4 2009($0.27)($0.28)ViewN/AView Earnings Details
11/3/2009Q3 2009($0.30)($0.33)ViewN/AView Earnings Details
8/4/2009Q2 2009($0.25)($0.26)ViewN/AView Earnings Details
5/6/2009Q1 2009($0.43)($0.36)ViewN/AView Earnings Details
3/10/2009Q4 2008($0.45)($0.48)ViewN/AView Earnings Details
11/6/2008Q3 2008($0.45)($0.56)ViewN/AView Earnings Details
7/29/2008Q2 2008($0.48)($0.42)ViewN/AView Earnings Details
4/29/2008Q1 2008($0.66)($0.95)ViewN/AView Earnings Details
3/31/2008Q4 2007($4.53)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


MAKO Surgical (NASDAQ:MAKO) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for MAKO Surgical (NASDAQ:MAKO)

No dividend announcements for this company have been tracked by

Insider Trades

MAKO Surgical (NASDAQ MAKO) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for MAKO Surgical (NASDAQ:MAKO)

MAKO Surgical (NASDAQ MAKO) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/15/2012William D PruittDirectorBuy10,000$13.45$134,500.00View SEC Filing  
11/14/2012Christopher C DeweyDirectorBuy25,000$13.15$328,750.00View SEC Filing  
(Data available from 1/1/2013 forward)


MAKO Surgical (NASDAQ MAKO) News Headlines


SEC Filings

MAKO Surgical (NASDAQ:MAKO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


MAKO Surgical (NASDAQ:MAKO) Income Statement, Balance Sheet and Cash Flow Statement


MAKO Surgical (NASDAQ MAKO) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.